Articles

The Vardanants Center for Innovative Medicine presents to your attention the bonds issued by the Vardanants Medical Center, with a 3-year maturity and an annual yield of 12%.

This is the first time in Armenia that a medical institution is entering the stock exchange and raising capital through the capital market. The shareholders of "Vardanants" — Mr. L. Altunyan, Mr. A. Meliksetyan, and the Amber Capital investment fund, whose founding shareholders include the European Union and the European Bank for Reconstruction and Development (EBRD) — have approached this transaction with great care to make it as reliable and beneficial for investors as possible.

"We are genuinely interested in attracting the widest possible range of investors to accelerate the development of Vardanants. In 2025–2028, in addition to the project to acquire an ultra-modern 3 Tesla MRI scanner, the funds will be directed towards the development of human resources, medical, and digital technologies.

These include projects such as AI-based treatment quality control, continuous customer satisfaction monitoring, and providing second opinions for radiology and laboratory test results. We also plan to develop educational modules using advanced technologies, based on approximately 400 clinical protocols developed and annually updated at Vardanants. As a result, we expect to more than double the number of patients served," — notes Levon Altunyan, CEO of Vardanants.

How to purchase:

• Through the mobile application,
• By visiting any branch of the Bank,
• By downloading and completing the application form on the Bank’s website.

You can find the detailed terms of issuance and placement, as well as the final terms of the prospectus, at this link.